TCPL Packaging Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:15 pm

Quick Insight

TCPL Packaging Ltd, with a share price of 3,397 and a market capitalization of 3,084 Cr., is trading at a P/E ratio of 23.4 and boasts a robust ROE of 23.8% and an impressive ROCE of 20.0%. The company's OPM stands at 17%, with a net profit of 141 Cr. and reserves of 640 Cr. However, TCPL Packaging has significant borrowings amounting to ₹614 Cr., resulting in a high P/BV ratio of 6.43x and an ICR of 5.28x. The shareholding pattern indicates strong promoter holding at 55.74%, with limited FII and DII participation at 0.91% and 11.68%, respectively. With these figures in mind, investors should closely monitor the company's ability to manage its debt levels efficiently to ensure sustained growth and shareholder value.

Competitors of TCPL Packaging Ltd

All Competitor Stocks of TCPL Packaging Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:35 am

Below is a detailed analysis of the quarterly data for TCPL Packaging Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 409.00 Cr.. The value appears to be declining and may need further review. It has decreased from 410.00 Cr. (Mar 2025) to 409.00 Cr., marking a decrease of 1.00 Cr..
• For Expenses, as of Jun 2025, the value is 338.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 339.00 Cr. (Mar 2025) to 338.00 Cr., marking a decrease of 1.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Mar 2025) to 71.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 17.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 9.00 Cr..
• For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from 6.00% (Mar 2025) to 22.00%, marking an increase of 16.00%.
• For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 24.98. The value appears to be declining and may need further review. It has decreased from 38.79 (Mar 2025) to 24.98, marking a decrease of 13.81.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:54 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:14 pm

Below is a detailed analysis of the balance sheet data for TCPL Packaging Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
• For Reserves, as of Mar 2025, the value is 640.00 Cr.. The value appears strong and on an upward trend. It has increased from 521.00 Cr. (Mar 2024) to 640.00 Cr., marking an increase of 119.00 Cr..
• For Borrowings, as of Mar 2025, the value is 614.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 484.00 Cr. (Mar 2024) to 614.00 Cr., marking an increase of 130.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 305.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2024) to 305.00 Cr., marking an increase of 17.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,568.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,303.00 Cr. (Mar 2024) to 1,568.00 Cr., marking an increase of 265.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 703.00 Cr.. The value appears strong and on an upward trend. It has increased from 644.00 Cr. (Mar 2024) to 703.00 Cr., marking an increase of 59.00 Cr..
• For CWIP, as of Mar 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 57.00 Cr..
• For Investments, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 747.00 Cr.. The value appears strong and on an upward trend. It has increased from 607.00 Cr. (Mar 2024) to 747.00 Cr., marking an increase of 140.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,568.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,303.00 Cr. (Mar 2024) to 1,568.00 Cr., marking an increase of 265.00 Cr..

Notably, the Reserves (640.00 Cr.) exceed the Borrowings (614.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for TCPL Packaging Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 157.16. This value is within the healthy range. It has increased from 111.39 (Mar 24) to 157.16, marking an increase of 45.77.
• For Diluted EPS (Rs.), as of Mar 25, the value is 157.16. This value is within the healthy range. It has increased from 111.39 (Mar 24) to 157.16, marking an increase of 45.77.
• For Cash EPS (Rs.), as of Mar 25, the value is 240.12. This value is within the healthy range. It has increased from 190.04 (Mar 24) to 240.12, marking an increase of 50.08.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 707.43. It has increased from 577.72 (Mar 24) to 707.43, marking an increase of 129.71.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 707.43. It has increased from 577.72 (Mar 24) to 707.43, marking an increase of 129.71.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,945.34. It has increased from 1,693.83 (Mar 24) to 1,945.34, marking an increase of 251.51.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 337.84. This value is within the healthy range. It has increased from 287.91 (Mar 24) to 337.84, marking an increase of 49.93.
• For PBIT / Share (Rs.), as of Mar 25, the value is 254.88. This value is within the healthy range. It has increased from 209.27 (Mar 24) to 254.88, marking an increase of 45.61.
• For PBT / Share (Rs.), as of Mar 25, the value is 190.85. This value is within the healthy range. It has increased from 147.89 (Mar 24) to 190.85, marking an increase of 42.96.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 157.16. This value is within the healthy range. It has increased from 111.39 (Mar 24) to 157.16, marking an increase of 45.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 157.16. This value is within the healthy range. It has increased from 111.39 (Mar 24) to 157.16, marking an increase of 45.77.
• For PBDIT Margin (%), as of Mar 25, the value is 17.36. This value is within the healthy range. It has increased from 16.99 (Mar 24) to 17.36, marking an increase of 0.37.
• For PBIT Margin (%), as of Mar 25, the value is 13.10. This value is within the healthy range. It has increased from 12.35 (Mar 24) to 13.10, marking an increase of 0.75.
• For PBT Margin (%), as of Mar 25, the value is 9.81. This value is below the healthy minimum of 10. It has increased from 8.73 (Mar 24) to 9.81, marking an increase of 1.08.
• For Net Profit Margin (%), as of Mar 25, the value is 8.07. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 8.07, marking an increase of 1.50.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.07. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 8.07, marking an increase of 1.50.
• For Return on Networth / Equity (%), as of Mar 25, the value is 22.21. This value is within the healthy range. It has increased from 19.28 (Mar 24) to 22.21, marking an increase of 2.93.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.01. This value is within the healthy range. It has decreased from 23.20 (Mar 24) to 23.01, marking a decrease of 0.19.
• For Return On Assets (%), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 7.63 (Mar 24) to 8.87, marking an increase of 1.24.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.40, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.91. This value is within the healthy range. It has decreased from 0.93 (Mar 24) to 0.91, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.20. It has decreased from 1.21 (Mar 24) to 1.20, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.20 (Mar 24) to 1.23, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.79 (Mar 24) to 0.87, marking an increase of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.79. This value is within the healthy range. It has increased from 3.93 (Mar 24) to 4.79, marking an increase of 0.86.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 17.95 (Mar 24) to 0.00, marking a decrease of 17.95.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.52 (Mar 24) to 0.00, marking a decrease of 10.52.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 82.05 (Mar 24) to 0.00, marking a decrease of 82.05.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.48 (Mar 24) to 0.00, marking a decrease of 89.48.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 4.69 (Mar 24) to 5.28, marking an increase of 0.59.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.45. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.45, marking an increase of 0.64.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,709.63. It has increased from 2,492.04 (Mar 24) to 4,709.63, marking an increase of 2,217.59.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.66. This value is within the healthy range. It has increased from 1.62 (Mar 24) to 2.66, marking an increase of 1.04.
• For EV / EBITDA (X), as of Mar 25, the value is 15.32. This value exceeds the healthy maximum of 15. It has increased from 9.51 (Mar 24) to 15.32, marking an increase of 5.81.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.34. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 2.34, marking an increase of 1.02.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 82.04 (Mar 24) to 0.00, marking a decrease of 82.04.
• For Price / BV (X), as of Mar 25, the value is 6.43. This value exceeds the healthy maximum of 3. It has increased from 3.86 (Mar 24) to 6.43, marking an increase of 2.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.34. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 2.34, marking an increase of 1.02.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness